Cardiac effects of hexarelin in hypopituitary adults

European Journal of Pharmacology

Volumn 381, Issue 1, 1999, Pages 31-38

  Bisi, Gianni ^a   Podio, Valerio ^a   Valetto, Maria Rosa ^a   Broglio, Fabio ^a   Bertuccio, Giovanni ^a   Aimaretti, Gianluca ^a   Pelosi, Ettore ^a   Del Rio, Graziano ^b   Muccioli, Giampiero ^c   Ong, Hui ^d   Boghen, Muni Franklin ^a   Deghenghi, Romano ^e   Ghigo, Ezio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e Ardana   (France)

Author keywords

Growth hormone (GH) secretagogue; Growth hormone deficiency (GHD), adult; Haemodynamic; Hexarelin; Radionuclide imaging; Ventricular function, left

Indexed keywords

CATECHOLAMINE; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; HEXARELIN;

ARTICLE; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GROWTH HORMONE DEFICIENCY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HUMAN; HYPOPITUITARISM; INOTROPISM; INTRAARTERIAL DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL;

ADULT; FLUSHING; HEART; HEMODYNAMIC PROCESSES; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OLIGOPEPTIDES; RADIONUCLIDE ANGIOGRAPHY;

EID: 0032832165     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00537-3     Document Type: Article

References (48)

1. Amato G., Carella C., Fazio S., La Montagna G., Cittadini A., Sabatini D., Marciano-Mone C., Saccà L., Bellastella A. Body composition, bone metabolism and heart structure and function in Growth Hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J. Clin. Endocrinol. Metab. 77:1993;1671-1676.
2. Arvat E., Di Vito L., Maccagno B., Broglio F., Boghen M.F., Deghenghi R., Camanni F., Ghigo E. Effects of GHRP-2 and Hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol level in man. Comparison with the effects of GHRH, TRH, and hCRH. Peptides. 18:1997;885-891.
3. Bisi G., Podio V., Valetto M.R., Broglio F., Bertuccio G., Del Rio G., Arvat E., Boghen M.F., Deghenghi R., Muccioli G., Ong H., Ghigo E. Acute cardiovascular and hormonal effects of growth hormone (GH) and Hexarelin, a synthetic GH-releasing peptide, in humans. J. Endocrinol. Invest. 22:1999;266-272.
4. Bodart V., McNicoll N., Carriere P., Bouchard J.F. Identification and characterisation of a new GHRP receptor in the heart. Proc. 80th Annual Meeting of the Endocrine Society, New Orleans, LA. 1998;302.
5. Bowers C.Y., Veeraragavan K., Sethumadhavan K. Atypical growth hormone releasing peptides. Bercu B.B., Walker R.F. Growth Hormone II, Basic and Clinical Aspects. 1993;203-222 Springer-Verlag, New York, NY.
6. Burow R.D., Strauss H.W., Singlwton R., Pond M., Rehn T., Bailey I.K., Griffith L.C., Nickoloff E., Pitt B. Analysis of left ventricular function from multiple gated acquisition cardiac blood pool imaging. Comparison to contrast angiography. Circulation. 56:1977;1024-1028.
7. Chapman I.M., Pescovitz O.H., Murphy G., Treep T., Cerchio K.A., Krupa D., Getz P., Polvino W.J., Skiles E.H., Pezzoli S.S., Thorner M.O. Oral administration of growth hormone (GH)-releasing peptide mimetic MK-677 stimulates the GH/insulin growth factor axis in selected GH-deficient adults. J. Clin. Endocrinol. Metab. 82:1997;3455-3463.
8. Cittadini A., Cuocolo A., Merola B., Fazio S., Sabatini D., Nicolai E., Colao A., Longobardi S., Lombardi G., Saccà L. Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement. Am. J. Physiol. 267:1994;E219-E225.
9. Cittadini A., Stromer H., Katz S.E., Clark R., Moses A.C., Morgan J.P., Douglas P.S. Differential cardiac effects of growth hormone and insulin-like growth factor I in the rat. A combined in vivo and in vitro evaluation. Circulation. 93:1996;800-809.
10. Cuocolo A., Nicolai E., Colao A., Longobardi S., Cardei S., Fazzio S., Merola B., Lombardi G., Saccà L., Salvatore M. Improved left ventricular function after growth hormone replacement in patients with hypopituitarism: assessment with radionuclide angiography. Eur. J. Nucl. Med. 23:1996;390-394.
11. De Boer H., Block G., van der Veen E.A. Clinical aspects of growth hormone deficiency in adults. Endocrinol. Rev. 16:1995;63-86.
12. De Gennaro Colonna V., Rossoni G., Bernareggi M., Muller E.E., Berti F. Cardiac ischemia and impairment of vascular endothelium function in hearts from GH-deficient rats: protection by hexarelin. Eur. J. Pharmacol. 334:1997;201-207.
13. D'Ercole A.J., Sites A.D., Underwood L.E. Tissue concentration of Somatomedic-C; further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc. Natl. Acad. Sci. U. S. A. 81:1984;935-939.
14. Donath M.Y., Zapf J., Eppenberger-Eberhardt M., Froesch E.R., Eppenberger H.M. Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle-actin of adult cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 91:1994;1686-1690.
15. Donath M.Y., Jenni R., Brunner H.P., Anrig M., Kohli S., Glatz Y., Froesch E.R. Cardiovascular and metabolic effects of Insulin-like Growth Factor-I at rest and during exercise in humans. J. Clin. Endocrinol. Metab. 81:1996;4089-4094.
16. Donath M.Y., Sutsch G., Yan X.W., Piva B., Brunner H.P., Glatz Y., Zpaf J., Follath F., Froesch E.R., Kiowski W. Acute cardiovascular effect of insulin-like growth factor I in patients with chronic heart failure. J. Clin. Endocrinol. Metab. 83:1998;3177-3183.
17. Donohue T.J., Dworkin L.D., Lango M.N., Friegner K., Lango R.P., Benstein J.A., Slater W.R., Catanese V.M. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation. 89:1994;799-809.
18. Duerr R.L., Huang S., Miraliakbar H.R., Clark R., Kien K.R., Ross J. Insulin-like Growth Factor-I enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J. Clin. Invest. 95:1995;619-627.
19. Fazio S., Sabatini D., Capaldo B., Vigorito C., Giordano A., Guida R., Pardo F., Biondi B., Saccà L. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N. Engl. J. Med. 334:1996;809-814.
20. Ghigo E., Arvat E., Muccioli G., Camanni F. Growth hormone-releasing peptides. Eur. J. Endocrinol. 136:1997;445-460.
21. Consensus guidelines for diagnosis and treatment of adults with severe GH deficiency. J. Clin. Endocrinol. Metab. 83:1998;379-381.
22. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinhji D.J.S., Smith R.G., Van der Ploeg L.H.T., Howard A.D. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol. Brain Res. 48:1997;23-29.
23. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Libarator P.A., Rosenblum C., Uamelin M., Ureniuk D.I., Palyme O.C., Anderson J., Paress P.S., Diaz C., Choun Liu K.K., Pong S.S., Cheung L.Y., Elbrecht A., Dashkeiviez M., Keavens R., Rishy M., Siringjhsinghji D.I.S., Dean D.C., Melillo D.G., Patchett A.A., Nergund R., Srillin P.R. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 273:1996;974-977.
24. Isgaard J., Nilsson A., Vilkman K., Isaksson O.G.P. Growth Hormone regulates the level of Insulin-Like Growth Factor mRNA in rat skeletal muscle. J. Endocrinol. 120:1989;107-112.
25. Isgaard J., Kujacic V., Jennische E., Holmang A., Sun X.Y., Hedner T., Hjalmarson A., Bengtsson B.A. Growth hormone improves cardiac function in rats with experimental myocardial infarction. Eur. J. Clin. Invest. 27:1997;517-525.
26. Isgaard J., Tivesten A., Bollano E., Kujacic V., Caidahl K., Sun X.Y., Hedner T., Hjalmarson A., Bengtsson B.A. The growth hormone secretagogue Hexarelin improves cardiac function in rats after experimental myocardial infarction. Proc. IV European Congress of Endocrinology, Sevilla, Spain. 1998;. OR 3-7.
27. Ito H., Hiroe M., Hirata Y., Tsujino M., Adaki S., Shichiri M., Koike A., Nogami A., Marumo F. Insulin-Like Growth Factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation. 87:1993;1715-1721.
28. Johannsson G., Bengtsson B.A., Andersson B., Isgaard J., Caidahl K. Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients. Clin. Endocrin. 45:1996;305-314.
29. Leal-Cerro A., Garcia E., Astorga R., Casanueva F.F., Dieguez C. Growth hormone (GH) responses to the combined administration of GH-releasing hormone plus GH-relising peptide 6 in adults with GH deficiency. Eur. J. Endocrinol. 132:1995;712-715.
30. Links J.M., Becker L.C., Shindledecker J.G., Guzman P., Burow R.D., Nickoloff E.L., Alderson P.O., Wagner H.N. Measurement of absolute left ventricular volume from gated blood pool studies. Circulation. 65:1982;82-91.
31. Longobardi S., Cuocolo A., Merola B., Di Rella F., Coalo A., Nicolai E., Cardei S., Salvatore M., Lombardi G. Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clin. Endocrinol. 48:1998;137-143.
32. Mangieri E., Tosti-Croce C., Tanzilli G., Barillà F., Nardi M., Poggi M., Ciavolella M., Farinelli A., Mangiaracina F., Campa P.P. Impairment of Growth Hormone/Insulin-like Growth Factor-I axis in normopituitaric patients with biventricular cardiac failure and hepatic stasis. Cardiologia. 41:1996;449-453.
33. Merola B., Cittadini A., Colao A., Longobardi S., Fazio S., Sabatini D., Saccà L., Lombardi G. Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J. Clin. Endocrinol. Metab. 77:1993;1658-1661.
34. Muccioli G., Ghè C., Ghigo M.C., Papotti M., Arvat E., Boghen M.F., Nillsom M.H.L., Deghenghi R., Ong H., Ghigo E. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J. Endocrinol. 156:1998;. in press.
35. Muccioli G., Ghhè C., Papotti M., Boghen M.F., Nillson M., Deghenghi R., Ong H., Ghigo E. Tissue distribution of GHRP receptors in humans. Proc. IV European Congress of Endocrinology, Sevilla, Spain. 1998;. OR 15-7.
36. Okada R.D., Kirshenbaum H.D., Kushner F.G., Strauss H.W., Dinsmore R.E., Newell J.B. Observer variance in the qualitative evaluation of left ventricular wall motion and the quantitation of left ventricular ejection fraction using rest and exercise multigated blood pool imaging. Circulation. 61:1990;128-136.
37. Ong H., Bodart V., McNicoll N., Lamontaigne D., Bouchard J.F. Binding sites for growth hormone-releasing peptide. Proc. 24th International Symposium GH and growth factors in endocrinology and metabolism, Antwerp. 1997;137.
38. 125I]p-benzoyl-phenylalanine Hexarelin derivative. Endocrinology. 139:1998;432-435.
39. Osterziel K.J., Strohm O., Schuler J., Friedrich M., Hanlen D., Willenbrock R., Anker S.D., Poole-Wilson P.A., Ranke M.B., Dietz R. Randomized, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet. 351:1998;1233-1237.
40. Rossoni G., De Gennaro Colonna V., Bernareggi M., Polvani G.M., Muller E.E., Berti F. Protectant activity of Hexarelin or growth hormone against post-ischemic ventricular dysfunction in hearts from aged rats. J. Cardiovasc. Pharmacol. 1999;. in press.
41. Russel Jones D.L., Bates A.I., Umpleby A.M., Hennessy T.R., Bowes S.V., Hopkins K.D. A comparison of the effect of IGF-I and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteers. Eur. J. Endocrinol. 25:1995;403-411.
42. Saccà L., Cittadini A., Fazio S. Growth hormone and the heart. Endocrinol. Rev. 15:1994;555-573.
43. Salomon F., Cuneo R.C., Hesp R., Sonksen P. The effect of treatment with recombinant human growth hormone on body composition and metabolism in adult with growth hormone deficiency. N. Engl. J. Med. 321:1989;1797-1803.
44. Shahi M., Beshyah S.A., Hackett D., Sharp P.S., Johnston D.G., Foale R.A. Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. Br. Heart J. 67:1992;92-96.
45. Smith R.G., Van der Ploeg L.X.T., Howard A.D., Feighner S.D., Chang K., Hickey G.J., Wyvratt M.J., Fisher M.H., Nargunt R.P., Patchett A.A. Peptidomimetic regulation of growth hormone secretion. Endocrinol. Rev. 18:1997;621-645.
46. Timsit J., Riou B., Bertherat J., Wisnewskj C., Kato N., Weisberg A., Lubetzki J., Le Carpentier Y., Winegrad S., Mercadier J.J. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle. J. Clin. Invest. 86:1990;507-515.
47. Volterrani M., Desenzani P., Lorusso R., D'Aloia A., Manelli F., Giustina A. Haemodynamic effects of intravenous growth hormone in congestive heart failure. Lancet. 359:1997;1067-1068.
48. Yang R., Bunting S., Gillett N., Clark R., Jin H. Growth hormone improves cardiac performance in experimental heart failure. Circulation. 92:1995;262-267.